Evidence map›Paper›PMID 32426265›Full record

ArticleFrontiers in oncology2020

Hemoglobin Levels and Red Blood Cells Distribution Width Highlights Glioblastoma Patients Subgroup With Improved Median Overall Survival.

Tehila Kaisman-Elbaz, Yonatan Elbaz, Vladimir Merkin, Lianne Dym, Ariel Noy, Maya Atar-Vardi, Romi Bari, Sivan Turiel, Adi Alt, Tali Zamed and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tehila Kaisman-ElbazDepartment of Neurosurgery, Soroka University Medical Center, Be'er Sheva, Israel.
Yonatan ElbazPhysics Department, Nuclear Research Center - Negev, Be'er Sheva, Israel.
Vladimir MerkinDepartment of Neurosurgery, Soroka University Medical Center, Be'er Sheva, Israel.
Lianne DymFaculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Ariel NoyFaculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Maya Atar-VardiClinical Research Center, Soroka University Medical Center, Be'er Sheva, Israel.
Romi BariClinical Research Center, Soroka University Medical Center, Be'er Sheva, Israel.
Sivan TurielClinical Research Center, Soroka University Medical Center, Be'er Sheva, Israel.
Adi AltDepartment of Neurosurgery, Soroka University Medical Center, Be'er Sheva, Israel.
Tali ZamedFaculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Yael EskiraDepartment of Neurosurgery, Soroka University Medical Center, Be'er Sheva, Israel.
Konstantin LavrenkovFaculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Yarden KezerleInstitute of Pathology, Soroka University Medical Center, Be'er Sheva, Israel.
Victor DyominInstitute of Pathology, Soroka University Medical Center, Be'er Sheva, Israel.
Israel MelamedDepartment of Neurosurgery, Soroka University Medical Center, Be'er Sheva, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma multiforme (GBM) is known for its dismal prognosis, though its dependence on patients' readily available RBCs parameters is not fully established. In this work, 170 GBM patients, diagnosed and treated in Soroka University Medical Center (SUMC) over the last 12 years were retrospectively inspected for their survival dependency on pre-operative RBCs parameters. Besides KPS and tumor resection supplemented by oncological treatment, age under 70 (HR = 0.4, 95% CI 0.24-0.65,

Indexed as

glioblastoma multiforme (GBM)hemoglobinoverall survivalprognostic factorsRDW (red cell distribution width)

Identifiers

PMID32426265
PMCPMC7212453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.